LOG IN
SIGN UP
MARKET
VALN
VALN
Valneva Se
NASDAQ
14.11
-0.05
-0.35%
Closed 16:00 02/03 EST
OPEN
14.18
PREV CLOSE
14.16
HIGH
14.56
LOW
14.07
VOLUME
7.10K
TURNOVER
88.08K
52 WEEK HIGH
40.70
52 WEEK LOW
9.77
MARKET CAP
976.07M
P/E (TTM)
-4.7448
1D
5D
1M
3M
1Y
5Y
WHO maintains public health emergency on COVID but sees 'inflexion point' ahead
Seeking Alpha · 6d ago
EMA Published Clinical Data Supporting Use Of Covid-19 Vaccine Valneva In Adults Aged 18 To 50
Benzinga · 01/26 11:17
WHO sets Jan. 27 meeting to decide on COVID emergency
Seeking Alpha · 01/10 13:08
Valneva Touts Additional Positive Heterologous Booster Data From COVID-19 Vaccine Study
Benzinga · 01/03 11:41
BRIEF-Valneva SE - Data Show That Booster Dose Of Vla2001 Was Well Tolerated In Previously Bnt162b2 Or Mrna 1273 Vaccinated Participants
Reuters · 12/30/2022 18:46
Valneva Concludes FDA Regulatory Submission For One-Shot Chikungunya Vaccine
Benzinga · 12/23/2022 16:04
Valneva Says it Completed Rolling US Regulatory Submission for One-Shot Chikungunya Vaccine Candidate
Valneva Says it Completed Rolling US Regulatory Submission for One-Shot Chikungunya Vaccine Candidate
MT Newswires · 12/23/2022 04:37
France Health Body Advises Unfavorable Opinion Regarding Valneva's COVID-19 Vaccine
Benzinga · 12/08/2022 15:21
About VALN
Valneva SE is a France-based company that specializes in the development, manufacture and commercialization of vaccines to protect people from infectious diseases through preventative medicine. The Company's portfolio includes two commercial vaccines for travelers: IXIARO/JESPECT, for the prevention of Japanese Encephalitis, and DUKORAL, which is indicated for the prevention of cholera and, in some countries, prevention of diarrhea caused by Enterotoxigenic escherichia coli (ETEC). The Company has also vaccines in development, including candidates against Lyme disease, COVID-19 and chikungunya. Its technologies and services segment cooperates with various pharmaceutical companies using its platform: EB66 vaccine production cell line and IC31 adjuvant. The Company is focused on research and development (R&D) programs, as well as holds investment in product candidates and commercial products.
Webull offers kinds of Valneva SE stock information, including NASDAQ:VALN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VALN stock news, and many more online research tools to help you make informed decisions.
You can practice and explore trading VALN stock methods without spending real money on the virtual paper trading platform.